Evidence map›Paper›PMID 42738383›Full record

ArticleCancers2026

The Global Immune-Nutrition-Inflammation Index (GINI) as a Candidate Prognostic Marker in Patients with Cutaneous Squamous Cell Carcinoma Treated with Cemiplimab.

Tara Coreanu, Ido Amir, Nofar Edri, Itamar Averbuch, Aviram Mizrachi, Amit Ritter, Moran Amit, Noga Kurman, Eyal Yosefof, Dan Yaniv

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tara CoreanuDepartment of Otorhinolaryngology and Head and Neck Surgery, Rabin Medical Center, Beilinson Hospital, Petah Tikva 4941492, Israel.
Ido AmirDepartment of Otorhinolaryngology and Head and Neck Surgery, Rabin Medical Center, Beilinson Hospital, Petah Tikva 4941492, Israel.
Nofar EdriDepartment of Otorhinolaryngology and Head and Neck Surgery, Rabin Medical Center, Beilinson Hospital, Petah Tikva 4941492, Israel.
Itamar AverbuchGray Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.
Aviram MizrachiDepartment of Otolaryngology-Head and Neck Surgery, Weill Cornell Medical College, Cornell University, New York, NY 10022, USA.
Amit RitterDepartment of Otorhinolaryngology and Head and Neck Surgery, Rabin Medical Center, Beilinson Hospital, Petah Tikva 4941492, Israel.
Moran AmitDepartment of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Noga KurmanGray Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.
Eyal YosefofGray Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.ORCID 0000-0001-8211-9774
Dan YanivDepartment of Otorhinolaryngology and Head and Neck Surgery, Rabin Medical Center, Beilinson Hospital, Petah Tikva 4941492, Israel.ORCID 0000-0002-0654-1161

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CemiplimabcSCCGINI

Identifiers

PMID42738383
PMCPMC13565106

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.